4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
ACUTE MYELOID LEUKEMIA
Acute Myeloid Leukemia
Dr Ira Shah
M.D, DCH(Gold Medalist), FCPS, DNB
Edited by Dr. Bharat R Agarwal
Consultant Pediatric Hematologist and Oncologist.


Q. How is AML classified?

A. The French-American-British classification system divides AML into 7 types -

M1 - Acute myeloblastic leukemia without maturation.
M2 - Acute myeloblastic leukemia with maturation.
M3 - Acute promyelocytic leukemia.
M4 - Acute myelomonocytic leukemia
M5 - Acute monocytic leukemia
M6 - Acute erythroleukemia
M7 - Acute megakaryocytic leukemia

M0 category is not officially recognized as part of AML as it lacks definitive myeloid differentiation by morphology or conventional cytochemistry but shows evidence of AML by ultrastructural or immunophenotyping.

Identification of AML subtypes is important because several new drugs have more activity against some variety of AML as against others. Also, prognosis and some clinical features may differ considerably among various AML sub-types.

Q. How is AML diagnosed?

A. On clinical suspicion, a complete hemogram and peripheral smear examination should be done which may aide in suspicion of leukemia in most cases. Peripheral WBC count may be increased, decreased or normal with equal frequency. Granulocytopenia is common. Thrombocytopenia, with a platelet count <20,000/ul is also common. Hematocrit is generally low.

Bone marrow aspiration and examination is usually diagnostic. Bone marrow biopsy may be required to assess cellularity. AML is diagnosed when bone marrow has more than 30% blasts. The bone marrow aspirate is stained with special histochemical stains to distinguish between AML and ALL and to confirm their diagnosis. The stains most commonly used include myeloperoxidase, PAS, Sudan Black B and esterase. (ALL stains with only PAS).

Bone marrow aspirate should also be sent for karyotyping and immunophenotyping as it helps in both type-classification and prognosis.

AML can also be diagnosed by biopsy of a chloroma. In addition, base line biochemical profile, X-Ray chest, coagulation screen and CSF examination are required.

Q. What are the prognostic factors in AML?

A. The various unfavorable factors are -
  • Hyperleukocytosis (WBC count > 1,00,000/cumm)
  • Secondary AML/MDS.
  • Monosomy 7 or 7q-
  • Aneuoploidy
  • Trisomy 8
  • Abnormalities of Chromosome 11 at band q23.
  • FAB type M7.

The favorable factors include.
  • FAB type M2 ,M3 , M4
  • Inversion of chromosome 16.
  • Reactivity with CD2 (T1).
  • T (8;21) and T (15;17) abnormality

 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us